相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multicenter Photopheresis Intervention Trial in Early-Stage Mycosis Fungoides
Rakhshandra Talpur et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2011)
Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
Elise A. Olsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Survival Outcomes and Prognostic Factors in Mycosis Fungoides/Sezary Syndrome: Validation of the Revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer Staging Proposal
Nita Sally Agar et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cutaneous T cell lymphoma and graft-versus-host disease: A comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+regulatory T cells
Vidar Rao et al.
CLINICAL IMMUNOLOGY (2009)
Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma
Kelley A. Vidulich et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2009)
Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells
Erin Gatza et al.
BLOOD (2008)
FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with stage and survival
L. M. Gjerdrum et al.
LEUKEMIA (2007)
Review of extracorporeal photopheresis in early-stage (IA, IB, and IIA) cutaneous T-cell lymphoma
Janine D. Miller et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2007)
Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Elise Olsen et al.
BLOOD (2007)
Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma
Madeleine Duvic et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Incidence of cutaneous T-Cell lymphoma in the United States, 1973-2002
Vincent D. Criscione et al.
ARCHIVES OF DERMATOLOGY (2007)
FDA approval summary: Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma
Bhupinder S. Mann et al.
ONCOLOGIST (2007)
Potential mechanisms of photopheresis in hematopoietic stem cell transplantation
D Peritt
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells
A Maeda et al.
JOURNAL OF IMMUNOLOGY (2005)
The immunological effects of extracorporeal photopheresis unraveled: Induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo
A Lamioni et al.
TRANSPLANTATION (2005)
Immunopathogenesis and therapy of cutaneous T cell lymphoma
EJ Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Transition of Sezary syndrome into mycosis fungoides after complete clinical and molecular remission under extracorporeal photophoresis
C Assaf et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome - Clinical prognostic factors and risk for disease progression
YH Kim et al.
ARCHIVES OF DERMATOLOGY (2003)
Sezary syndrome and seronegative polyarthritis:: Treatment with extracorporeal photochemotherapy
W Macheiner et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2003)
The Sezary syndrome: hematologic criteria
EC Vonderheid et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2003)
A blast from the past: Clearance of apoptotic cells regulates immune responses
J Savill et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy - A 14-year experience at a single institution
KR Suchin et al.
ARCHIVES OF DERMATOLOGY (2002)
A modified staging classification for cutaneous T-cell lymphoma
M Kashani-Sabet et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: Multinational phase II-III trial results
M Duvic et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma
E Olsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Primary cutaneous T-cell lymphoma: Review and current concepts
RS Siegel et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Increased risk of secondary cancers in patients with primary cutaneous T cell lymphoma
L Väkevä et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)
分享论文
